Germany: Siemens Healthineers to buy Varian for US$16.4bn

Bernd Montag, chief executive officer, Siemens Healthineers

Germany’s Siemens Healthineers has said that it will acquire US cancer care specialist Varian for US$16.4bn. Siemens Healthineers will acquire all shares of Varian for US$177.50 per share in cash. This is a 24.4% premium to the closing price of Varian shares in New York on Friday, according to Bloomberg. “With this combination of two…

You must be a HMI Subscriber to view this content. Please log in or subscribe below.

Subscribe Now »